switching from tirzepatide to retatrutide dosage Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Switching From Tirzepatide to Retatrutide

Typical range 50 to 300 per month depending on support level Bundled model where medication is prescribed by the telehealth partner and coaching is an add on

Tirzepatide combines GLP-1 activity with GIP activity, another hormone involved in metabolic regulation, which may help explain why its weight-loss results have outpaced earlier medications in clinical trials

10.1016/j.niox.2014.05.003 [DOI] [PubMed] [Google Scholar] Guitard, R

"This is the most comprehensive review to date of long-term cardiovascular outcome trials for GLP 1 receptor agonists

Since only three contrasts reported a positive association, we did not test for a positive association of GLP-1 with reward-related brain responses